Pliant Therapeutics, Inc. Price Today

image quote

Pliant Therapeutics, Inc.

PLRX

Healthcare

$886.72M

๐Ÿ’ฐ

Market Cap

0

๐Ÿ’ธ

Price to Earnings

$-2.8

๐ŸŽ‰

EPS

+0

๐ŸŒณ

ESG
Consensus Recommendations

Buy Consensus

Buy
12
Strong Buy
7
Hold
1
Sell
0
Strong Sell
0

PLRX Price Forecast Target

14.7 ๐Ÿ‘‰ 54.0 +267%

PLRX EPS Forecast

-2.8 ๐Ÿ‘‰ -3.5 +26%
Financials

Profit Margin

0 %

Revenue Growth

-100.0 %

Dividend

$ 0
Held Percent
6.6% - Insiders 110.8% - Institutions -17.4% - Public
Major Fund Holders
  • ๐Ÿ’ฐ Deep Track Capital, Lp $84.6M
  • ๐Ÿ’ฐ Blackrock Inc. $70.7M
  • ๐Ÿ’ฐ FMR, LLC $58.3M
  • ๐Ÿ’ฐ Price (T.Rowe) Associates Inc $55.7M
  • ๐Ÿ’ฐ First Light Asset Management, LLC $52.9M
Stock Ideas
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a tโ€ฆ
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signiโ€ฆ
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and โ€ฆ
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track reโ€ฆ

๐Ÿ“ฎFAQ

Some Frequently Asked Questions.

rocket money aiovel
The Pliant Therapeutics, Inc. industry is Biotechnology

rocket money aiovel
The Pliant Therapeutics, Inc. sector is Healthcare

rocket money aiovel
The Pliant Therapeutics, Inc. forecasted predicted Price to Earnings PE ratio is -4.2

rocket money aiovel
The Pliant Therapeutics, Inc. Price to Earnings PE ratio is 0

rocket money aiovel
The Market Capitalization of Pliant Therapeutics, Inc. is $886.72M

rocket money aiovel
There are total of 47094988 float shares with 110.8% held by Institutions and 6.6% held by insiders

rocket money aiovel
The MPliant Therapeutics, Inc. forecasted Earnings per Share EPS is $-3.5

rocket money aiovel
The Pliant Therapeutics, Inc. Earnings per Share EPS is -2.8

rocket money aiovel
The Pliant Therapeutics, Inc. company has $0 gross profits with 0 profit margins

rocket money aiovel
The Pliant Therapeutics, Inc. Earnings Growth is 0% with 0% quarterly earnings growth

rocket money aiovel
The Pliant Therapeutics, Inc. Revenue is $1580000 with -1.0 revenue growth

rocket money aiovel
The price target for Pliant Therapeutics, Inc. stock is $54.0 for the high target and $24.0 for the low target

rocket money aiovel
The consensus analyst recommendations for Pliant Therapeutics, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.

rocket money aiovel
The consensus analyst recommendations for Pliant Therapeutics, Inc. is Buy, with the following breakdown:
  • Buy: 12
  • Strong Buy: 7
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0

rocket money aiovel
The Beta of Pliant Therapeutics, Inc. is 1.1

rocket money aiovel
The dividend of Pliant Therapeutics, Inc. is $0

rocket money aiovel
The dividend yield of Pliant Therapeutics, Inc. is 0%

rocket money aiovel
The biggest institutional and mutual fund holders of Pliant Therapeutics, Inc. stock are
  • Deep Track Capital, Lp
  • Blackrock Inc.
  • FMR, LLC
  • Price (T.Rowe) Associates Inc

rocket money aiovel
The Pliant Therapeutics, Inc. ESG Score is 0, with the following breakdown:
  • E: 0
  • S: 0
  • G: 0
PLRX Stock
Pliant Therapeutics, Inc. Stock Symbol
PLRX Share
PLRX Stock Price
PLRX Shares Price
PLRX Stock Market Predictions
PLRX Stock Targets
PLRX Stock Analysis
PLRX Stock Screener
PLRX Stock Forecast
PLRX Stock Price
PLRX Stock Graph
PLRX Stock Chart
PLRX Stock Dividend
Pliant Therapeutics, Inc. Earnings
Pliant Therapeutics, Inc. buy sell or hold
Pliant Therapeutics, Inc. Net Worth
PLRX pre market price
PLRX market value
PLRX ESG rating